PCSA
Processa Pharmaceuticals Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$2.95
+0.19 ▲ +6.88%
🌙 3월 13일 4:39 PM ET (한국 3/14 05:39)
$2.98
+0.03 ▲ +1.02%
| Index | - | P/E | - | EPS (ttm) | -34.02 | Insider Own | 15.44% | Shs Outstand | 0.00B | Perf Week | 4.24% |
| Market Cap | 0.01B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 0.00B | Perf Month | 20.41% |
| Enterprise Value | 0.00B | PEG | - | EPS next Q | - | Inst Own | 5.08% | Short Float | 0.54% | Perf Quarter | -57.39% |
| Income | -0.01B | P/S | - | EPS this Y | - | Inst Trans | 6.39% | Short Ratio | 0.01 | Perf Half Y | -38.51% |
| Sales | 0.00B | P/B | 1.07 | EPS next 5Y | - | ROA | -206.5% | Short Interest | 0.01M | Perf YTD | 2.43% |
| Book/sh | 2.76 | P/C | 1.06 | EPS past 3/5Y | 36.21% 22.65% | ROE | -270.74% | 52W High | -84.98% ($19.63) | Perf Year | -73.63% |
| Cash/sh | 2.79 | P/FCF | - | Sales past 3/5Y | - | ROIC | -221.71% | 52W Low | 67.61% ($1.76) | Perf 3Y | -98.89% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 72.88% | Gross Margin | - | Volatility(W/M) | 11.28% 12.14% | Perf 5Y | -99.95% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.31 | Perf 10Y | -99.97% |
| Dividend Ex-Date | - | Quick Ratio | 3.76 | EPS Q/Q | 93% | Profit Margin | - | RSI (14) | 57.76 | Recom | 2 |
| Dividend Gr. 3/5Y | - | Current Ratio | 3.76 | Sales Q/Q | - | SMA20 | 20.43% ($2.45) | Beta | 0.91 | Target Price | $25 |
| Payout | - | Debt/Eq | 0 | Earnings | 2025/11/05 | SMA50 | 6.53% ($2.77) | Rel Volume | 0.06 | Prev Close | $2.76 |
| Employees | 10 | LT Debt/Eq | 0 | EPS/Sales Surpr. | -13.64% - | SMA200 | -45.6% ($5.42) | Avg Volume(3M) | 0.81M | Price | $2.95 |
| IPO | 2013/11/21 | Option/Short | No/Yes | Trades | 292 | Volume | 52,000 | Change | 6.88% |
뉴스 로딩 중...